Patient Savings and Assistance
Auxilium, the maker of Testim, is committed to making treatment available and more affordable. With the Testim Savings Voucher, the Testim Access Hotline, and the Testim Patient Assistance Program, eligible patients can get the help they need. Testim is also covered by most health insurance plans in the United States.
Testim Savings Voucher
With Testim savings vouchers, your patients may be eligible to save up to $480 per year on the Testim prescriptions you give them.
Learn more about the Testim Savings Vouchers »
Testim Access Hotline
The Testim Access Hotline offers access to reimbursement information and support to patients, healthcare professionals, and their representatives.
Learn more about the Testim Access Hotline »
Insurance Coverage
Most health insurance plans in the United States cover Testim; however, coverage and co-pays differ from plan to plan.
Learn more about insurance coverage for Testim »
Information for Patients Enrolled in Medicare Part D
Men who are enrolled in the Medicare Part D prescription drug benefit program can often receive coverage for Testim.
Learn more about Testim coverage under Medicare Part D »
Testim Patient Assistance Program
The Testim Patient Assistance Program has been established to offer Testim at no charge to eligible patients in financial need.
Learn more about the Patient Assistance Program »
Indication
Testim 1% (testosterone gel) is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Important Safety Information
WARNING: SECONDARY EXPOSURE TO TESTOSTERONE
Virilization has been reported in children who were secondarily exposed to testosterone gel. Children should avoid contact with unwashed or unclothed application sites in men using testosterone gel. Healthcare providers should advise patients to strictly adhere to recommended instructions for use.
Androgens are contraindicated in men with cancer of the breast or known or suspected cancer of the prostate. Testim is not indicated for women and must not be used in women. Pregnant and nursing women should avoid skin contact with Testim application sites on men. Testosterone may cause fetal harm, or harm a breast-feeding baby.
Testim should not be used in patients with known hypersensitivity to testosterone or any of the ingredients in Testim, including soy.
Men treated with androgens may be at an increased risk for prostate cancer, or the development or worsening of benign prostatic hyperplasia.
Testim is not meant for use in women. If you are pregnant, may become pregnant, or are breast-feeding, Testim may harm your unborn or breast-feeding baby. Women who are pregnant or who may become pregnant should avoid contact with the area where Testim has been applied.
Virilization can occur in women and children secondarily exposed to testosterone. To minimize the potential for secondary exposure to testosterone from Testim-treated skin, patients should wash their hands thoroughly and immediately with soap and water after application of Testim and should cover the application site(s) with clothing after the gel has dried. Prior to any situation in which direct skin-to-skin contact is anticipated, patients should wash the application sites thoroughly with soap and water so as to remove any testosterone residue.
Other risks associated with the use of testosterone include: edema with or without congestive heart failure, gynecomastia, and potentiation of sleep apnea. Large doses of testosterone may suppress spermatogenesis.
The most common adverse events occurring with the use of Testim include: application site reaction, increase in hematocrit/hemoglobin, headache, and increase in blood pressure.
Please see Full Prescribing Information and Medication Guide.